ACME UNITED CORPORATION Recalls Wipes Plus Hand Sanitizing BZK Wipes Due to CGMP Deviations
ACME UNITED CORPORATION has issued a voluntary recall for several lots of Wipes Plus Hand Sanitizing Alcohol Free BZK Wipes due to manufacturing practice deviations.
What Happened
ACME UNITED CORPORATION has initiated a voluntary recall of several lots of Wipes Plus Hand Sanitizing Alcohol Free BZK Wipes. The recall, classified as a Class II event by the FDA, was triggered due to Current Good Manufacturing Practice (CGMP) deviations. The firm began the recall process on January 20, 2026, after identifying issues with the manufacturing standards for these products.
Which Products Are Affected
The recall affects Wipes Plus, Hand Sanitizing Alcohol Free BZK Wipes (Benzalkonium Chloride 0.13%), manufactured for CFS Brands DBA WipesPlus. The products are identified by NDC 67151-333-01.
The following specific lots and expiration dates are included in this recall:
- Lot MN16022: Expiration Date Aug 2027
- Lot MN33922: Expiration Date Apr 2027
- Lot MN31222: Expiration Date Apr 2027
- Lot MN16522: Expiration Date Oct 2027
- Lot MN17022: Expiration Date Apr 2027
- Lot MN03323: Expiration Date Jan 2028
- Lot MN34622: Expiration Date Oct 2027
These products were distributed nationwide within the United States.
What You Should Do
Consumers and distributors in possession of the affected lots should stop using or selling the product immediately. ACME UNITED CORPORATION initiated the recall via notification letters. For questions regarding this recall or instructions on how to handle affected inventory, consumers should contact ACME UNITED CORPORATION at their headquarters in Shelton, CT.
Why This Matters
This recall is significant because CGMP deviations indicate that the product may not have been manufactured under the strict quality and safety standards required by the FDA. Such deviations can impact the consistency, safety, and efficacy of the hand sanitizing wipes.
Source
Information provided by the FDA under Recall Number D-0368-2026.
Source: FDA Official Notice